Logo image of BMET.CA

BEMETALS CORP (BMET.CA) Stock Fundamental Analysis

TSX-V:BMET - TSX Venture Exchange - CA0813791096 - Common Stock - Currency: CAD

0.035  0 (0%)

Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to BMET. BMET was compared to 811 industry peers in the Metals & Mining industry. Both the profitability and financial health of BMET have multiple concerns. BMET does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year BMET has reported negative net income.
In the past year BMET has reported a negative cash flow from operations.
In the past 5 years BMET always reported negative net income.
In the past 5 years BMET always reported negative operating cash flow.
BMET.CA Yearly Net Income VS EBIT VS OCF VS FCFBMET.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -5M -10M

1.2 Ratios

Looking at the Return On Assets, with a value of -7.32%, BMET is in the better half of the industry, outperforming 65.72% of the companies in the same industry.
BMET's Return On Equity of -11.26% is fine compared to the rest of the industry. BMET outperforms 63.87% of its industry peers.
Industry RankSector Rank
ROA -7.32%
ROE -11.26%
ROIC N/A
ROA(3y)-21.75%
ROA(5y)-16.08%
ROE(3y)-29.8%
ROE(5y)-20.92%
ROIC(3y)N/A
ROIC(5y)N/A
BMET.CA Yearly ROA, ROE, ROICBMET.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1K -1K -2K -3K

1.3 Margins

BMET does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
BMET.CA Yearly Profit, Operating, Gross MarginsBMET.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024

More info and screens

1

2. Health

2.1 Basic Checks

Compared to 1 year ago, BMET has more shares outstanding
Compared to 5 years ago, BMET has more shares outstanding
The debt/assets ratio for BMET is higher compared to a year ago.
BMET.CA Yearly Shares OutstandingBMET.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
BMET.CA Yearly Total Debt VS Total AssetsBMET.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

2.2 Solvency

Based on the Altman-Z score of -0.89, we must say that BMET is in the distress zone and has some risk of bankruptcy.
BMET has a Altman-Z score (-0.89) which is in line with its industry peers.
A Debt/Equity ratio of 0.19 indicates that BMET is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.19, BMET is doing worse than 66.09% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.19
Debt/FCF N/A
Altman-Z -0.89
ROIC/WACCN/A
WACCN/A
BMET.CA Yearly LT Debt VS Equity VS FCFBMET.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M 30M

2.3 Liquidity

A Current Ratio of 0.26 indicates that BMET may have some problems paying its short term obligations.
BMET has a worse Current ratio (0.26) than 74.35% of its industry peers.
BMET has a Quick Ratio of 0.26. This is a bad value and indicates that BMET is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of BMET (0.26) is worse than 73.86% of its industry peers.
Industry RankSector Rank
Current Ratio 0.26
Quick Ratio 0.26
BMET.CA Yearly Current Assets VS Current LiabilitesBMET.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M

More info and screens

0

3. Growth

3.1 Past

BMET shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -2.44%.
EPS 1Y (TTM)-2.44%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%41.46%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for BMET. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
BMET.CA Price Earnings VS Forward Price EarningsBMET.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
BMET.CA Per share dataBMET.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.02 -0.02 0.04 0.06 0.08 0.1

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

BMET does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

BEMETALS CORP

TSX-V:BMET (6/27/2025, 7:00:00 PM)

0.035

0 (0%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)05-23 2025-05-23
Earnings (Next)08-25 2025-08-25
Inst Owners0.14%
Inst Owner ChangeN/A
Ins Owners14.95%
Ins Owner ChangeN/A
Market Cap8.01M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 0.34
P/tB 0.34
EV/EBITDA N/A
EPS(TTM)-0.01
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.02
FCFYN/A
OCF(TTM)0
OCFYN/A
SpS0
BVpS0.1
TBVpS0.1
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -7.32%
ROE -11.26%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-21.75%
ROA(5y)-16.08%
ROE(3y)-29.8%
ROE(5y)-20.92%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.19
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.26
Quick Ratio 0.26
Altman-Z -0.89
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-2.44%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%41.46%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y13.05%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y31.07%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y21.94%
OCF growth 3YN/A
OCF growth 5YN/A